NCT06734286 · RECRUITING
Working Memory Training in Patients with Mild Cognitive Impairment
This trial is testing CogMed, a computerized working memory training program, in people with mild cognitive impairment. Researchers want to know whether the training improves memory, reduces stress, and whether it changes a blood marker called p-Tau 217 that may reflect Alzheimer's-related brain changes. This is a Phase NA study, meaning it is a practical intervention trial rather than a drug study moving through standard approval phases.
You may qualify if
- Male or female outpatients ages ≥ 50 years;
- Meet Mayo Clinic Criteria for MCI. (Patients with mild cognitive impairment)
- Access to the internet through computer
- A proficiency in speaking and reading English or having a family member who is proficient in reading and speaking English and is willing to serve as a translator.
- Vision and hearing must be sufficient to comply with study procedures.
You're excluded if
- Mini Mental State Exam (MMSE) score less than 19 or patients diagnosed with moderate or severe dementia by a clinician.
- In the opinion of the investigator, participation would not be in the best interest of the subject.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-12-16